USPSTF: Evidence Lacking to Recommend Food Insecurity Screening
By Elana Gotkine HealthDay Reporter
TUESDAY, March 11, 2025 -- The U.S. Preventive Services Task Force (USPSTF) concludes that evidence is currently insufficient for food insecurity screening in primary care, and the balance of benefits and harms of screening for food insecurity cannot be determined. These findings form the basis of a final recommendation statement published online March 11 in the Journal of the American Medical Association.
Elizabeth A. O'Connor, Ph.D., from Kaiser Permanente in Portland, Oregon, and colleagues conducted a systematic review of the evidence on benefits and harms of screening and interventions for food insecurity in health care settings. The researchers found one randomized clinical study examining the impact of screening for food insecurity showed no difference in food insecurity after six months. Twenty-nine studies examined interventions to address food insecurity; 27 were rated as poor quality. Of the two fair-quality studies, one revealed that home delivery of medically tailored meals was associated with lower food insecurity, and the other showed a smaller increase in body mass index among children whose families participated in a mobile food bank after six months.
Based on these findings, the USPSTF concludes that the evidence is insufficient and the balance of benefits and harms of screening for food insecurity on health outcomes in the primary care setting cannot be determined (I statement).
"The most effective health-promoting solution would be to effectively end food insecurity through social policies and an augmented social safety net," Arvin Garg, M.D. M.P.H., from the UMass Memorial Children's Medical Center in Worcester, and colleagues write in an accompanying editorial.
Final Recommendation Statement
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-12 06:00
Read more

- Paxlovid May Offer Little Benefit for Vaccinated Older Adults
- FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
- Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
- Boehringer’s Zongertinib Receives Priority Review from U.S. FDA for the Treatment of HER2 (ERBB2)-Mutant Advanced Non-Small Cell Lung Cancer
- FDA Approves Romvimza (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor
- Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions